I. Subortseva

发表

Biology of Myeloproliferative Malignancies

A. Melikyan, I. Subortseva, A. Melikyan, 2016 .

[Clinical features of essential thrombocythemia and primary myelofibrosis, depending on the molecular characteristics of disease].

A. Sudarikov, A. Kovrigina, A. Melikyan, 2017, Terapevticheskii arkhiv.

National clinical recommendations for the diagnosis and treatment of mastocytosis

A. Sudarikov, A. Kovrigina, V. Savchenko, 2021, Russian journal of hematology and transfusiology.

[Thrombosis in patients with myeloproliferative neoplasms. Case report].

E. K. Egorova, A. Sudarikov, A. Kovrigina, 2021, Terapevticheskii arkhiv.

Stevens-Johnson Syndrome after Treatment of Female Patient with Small Lymphocytic B-Cell Lymphoma, Autoimmune Hemolytic Anemia and Antiphospholipid Antibody Syndrome with Rituximab

A. Kovrigina, A. Melikyan, I. Subortseva, 2017 .

Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases.

E. K. Egorova, A. Sudarikov, A. Kovrigina, 2018, Terapevticheskii arkhiv.

[Synchronous and metachronous myeloid and lymphoid tumors].

A. Sudarikov, V. Dvirnyk, A. Turkina, 2014, Terapevticheskii arkhiv.

[Clinical and morphological features of different types of Castleman's disease].

E. K. Egorova, V. Savchenko, V. Savchenko, 2015, Terapevticheskii arkhiv.

Kaposi’s sarcoma in HIV-negative patient with primary myelofi brosis

E. K. Egorova, A. Kovrigina, A. Melikyan, 2021, Russian journal of hematology and transfusiology.

[The prognostic value of ASXL1 mutation in primary myelofibrosis. Literature review and clinical case description].

E. K. Egorova, A. Sudarikov, A. Melikyan, 2020, Terapevticheskii arkhiv.

[Repeated haploidentical allogeneic hematopoietic stem cell transplantation with TCR αβ/CD19 depletion in patient with primary myelofibrosis. Case report].

E. Parovichnikova, V. Savchenko, L. Kuzmina, 2021, Terapevticheskii arkhiv.

Red Blood Cell Morphodynamics in Patients with Polycythemia Vera and Stroke

I. Subortseva, M. Tanashyan, P. Kuznetsova, 2022, International journal of molecular sciences.

Low JAK2 V617F Allele Burden in Ph-Negative Chronic Myeloproliferative Neoplasms Is Associated with Additional CALR or MPL Gene Mutations

A. Sudarikov, A. Kovrigina, S. Kulikov, 2021, Genes.

[Clinical features and diagnosis of Ph - negative myeloproliferative neoplasms occurring in conjunction with the antiphospholipid syndrome].

A. Melikyan, I. Subortseva, O. Margolin, 2019, Terapevticheskii arkhiv.

Resolution of the Expert Council on the issues of diagnosis and treatment of myeloproliferative neoplasms, existing standards and the possibility of their implementation in real clinical practice in Russia

A. Melikyan, I. Subortseva, 2022, Oncohematology.

Acute ischemic stroke in the setting of essential thrombocytemia (clinical cases).

A. Melikyan, I. Subortseva, M. Tanashyan, 2018, Terapevticheskii arkhiv.

National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)

B. Afanasyev, A. Sudarikov, A. Kovrigina, 2021 .

[Mastocytosis. Review of the literature and description of clinical cases].

A. Sudarikov, V. Dvirnyk, T. Obukhova, 2014, Terapevticheskii arkhiv.

[Experience in treating portal thromboses in patients with chronic myeloproliferative diseases].

E. B. Orel, A. Melikyan, I. Subortseva, 2016, Terapevticheskii arkhiv.

Cephalalgia against the background of systemic mastocytosis: a clinical case

A. Melikyan, I. Subortseva, M. Tanashyan, 2021, Bulletin of Siberian Medicine.

[Diagnosis of latent polycythemia vera: A clinician's opinion].

A. Sudarikov, A. Kovrigina, S. Kulikov, 2016, Terapevticheskii arkhiv.